Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
ADXS similar filings
- 9 Feb 24 Unregistered Sales of Equity Securities
- 6 Feb 24 Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
- 3 Jan 24 Consolidated Financial Statements
- 20 Oct 23 Ayala Pharmaceuticals Announces Closing of Merger with Biosight
- 21 Sep 23 Entry into a Material Definitive Agreement
- 1 Aug 23 Ayala Pharmaceuticals and Biosight Enter into Definitive Merger Agreement
- 7 Apr 23 Changes in Registrant's Certifying Accountant
Filing view
External links